188 related articles for article (PubMed ID: 8080616)
1. Structure-activity relationships of antitumor thiazolo[3,4-a]benzimidazole derivatives.
Chimirri A; Grasso S; Montforte AM; Montforte P; Zappalà M; Carotti A
Farmaco; 1994 May; 49(5):337-44. PubMed ID: 8080616
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives.
Luo Y; Xiao F; Qian S; Lu W; Yang B
Eur J Med Chem; 2011 Jan; 46(1):417-22. PubMed ID: 21115212
[TBL] [Abstract][Full Text] [Related]
3. Benzimidazole condensed ring systems. XII. Synthesis and anticancer evaluation of certain pyrido[1,2-a]benzimidazole derivatives.
el-Hawash SA; Badawey el-S A; Kappe T
Pharmazie; 1999 May; 54(5):341-6. PubMed ID: 10368827
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro evaluation of the anticancer activity of novel fluorinated thiazolo[4, 5-d]pyrimidines.
Fahmy HT; Rostom SA; Saudi MN; Zjawiony JK; Robins DJ
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):216-25. PubMed ID: 12916055
[TBL] [Abstract][Full Text] [Related]
5. Benzimidazole condensed ring systems 10 (1). Synthesis and cytotoxic activity of some pyrido[1,2-a]benzimidazoles.
Badawey ES; Kappe T
Farmaco; 1995; 50(7-8):537-42. PubMed ID: 7669192
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor evaluation of new thiazolo[5,4-b]quinoline derivatives.
Alvarez-Ibarra C; Fernández-Granda R; Quiroga ML; Carbonell A; Cárdenas F; Giralt E
J Med Chem; 1997 Feb; 40(5):668-76. PubMed ID: 9057853
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antitumor activity and SAR study of novel [1,2,4]triazino[4,5-a]benzimidazole derivatives.
El-Nassan HB
Eur J Med Chem; 2012 Jul; 53():22-7. PubMed ID: 22542105
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic evaluation of novel 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d]imidazole derivatives.
Ranganatha SR; Kavitha CV; Vinaya K; Prasanna DS; Chandrappa S; Raghavan SC; Rangappa KS
Arch Pharm Res; 2009 Oct; 32(10):1335-43. PubMed ID: 19898794
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of aminoadamantane derivatives for in vitro anti-HIV and antitumor activities.
da Settimo A; Marini AM; Primofiore G; Da Settimo F
Farmaco; 1995 May; 50(5):321-6. PubMed ID: 7626166
[TBL] [Abstract][Full Text] [Related]
10. Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Lenaz G; Fato R; Bergamini C; Farruggia G
J Med Chem; 2005 Apr; 48(8):3085-9. PubMed ID: 15828848
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor evaluation of new polysubstituted thiazole and derived thiazolo[4, 5-d]pyrimidine systems.
Fahmy HT; Rostom SA; Bekhit AA
Arch Pharm (Weinheim); 2002 May; 335(5):213-22. PubMed ID: 12210778
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2.
Tsuzuki Y; Tomita K; Shibamori K; Sato Y; Kashimoto S; Chiba K
J Med Chem; 2004 Apr; 47(8):2097-109. PubMed ID: 15056007
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumour activity of 1H,3H-thiazolo[3,4-a]benzimidazole derivatives.
Chimirri A; Monforte P; Musumeci L; Rao A; Zappalà M; Monforte AM
Arch Pharm (Weinheim); 2001 Jun; 334(6):203-8. PubMed ID: 11475910
[TBL] [Abstract][Full Text] [Related]
14. Facile synthesis and in-vitro antitumor activity of some pyrazolo[3,4-b]pyridines and pyrazolo[1,5-a]pyrimidines linked to a thiazolo[3,2-a]benzimidazole moiety.
Abdel-Aziz HA; Saleh TS; El-Zahabi HS
Arch Pharm (Weinheim); 2010 Jan; 343(1):24-30. PubMed ID: 19921685
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.
Roth T; Morningstar ML; Boyer PL; Hughes SH; Buckheit RW; Michejda CJ
J Med Chem; 1997 Dec; 40(26):4199-207. PubMed ID: 9435891
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues.
Congiu C; Cocco MT; Onnis V
Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles.
Singh M; Tandon V
Eur J Med Chem; 2011 Feb; 46(2):659-69. PubMed ID: 21186067
[TBL] [Abstract][Full Text] [Related]
18. First synthesis of an aziridinyl fused pyrrolo[1,2-a]benzimidazole and toxicity evaluation towards normal and breast cancer cell lines.
Bonham S; O'Donovan L; Carty MP; Aldabbagh F
Org Biomol Chem; 2011 Oct; 9(19):6700-6. PubMed ID: 21808774
[TBL] [Abstract][Full Text] [Related]
19. One-pot synthesis of new (1,3-thiazolo[5,4-b]pyridin-2-yl)benzenediols and their antiproliferative activities against human cancer cell lines.
Matysiak J; Karpińska MM; Niewiadomy A; Wietrzyk J; Kłopotowska D
Chem Biodivers; 2012 Jan; 9(1):48-57. PubMed ID: 22253102
[TBL] [Abstract][Full Text] [Related]
20. Antineoplastic activity of the thiazolo[5,4-b]quinoline derivative D3CLP in K-562 cells is mediated through effector caspases activation.
González-Sánchez I; Solano JD; Loza-Mejía MA; Olvera-Vázquez S; Rodríguez-Sotres R; Morán J; Lira-Rocha A; Cerbón MA
Eur J Med Chem; 2011 Jun; 46(6):2102-8. PubMed ID: 21420205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
